Work

Pcn241 Costs of Cytokine Release Syndrome (crs) and Neurological Events (ne) in Patients With Relapsed/refractory Non-hodgkin Lymphoma Receiving Lisocabtagene Maraleucel (liso-cel) in the Transcend Nhl 001 Clinical Trial: a Micro-costing Study From the Spanish National Health System (nhs) Perspective

Year: 2019

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2019.09.436

Authors: M. Presa, C. Varela, I. Oyagüez

Institution: Pharmacoeconomics and Health Outcomes Research Iberia (Spain)

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2995437162

Cites:

Cited by:

Related to: 10